[Federal Register Volume 84, Number 204 (Tuesday, October 22, 2019)]
[Notices]
[Page 56474]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-23012]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

[Docket No. DEA-524]


Bulk Manufacturer of Controlled Substances Application: Johnson 
Matthey, Inc.

ACTION: Notice of application.

-----------------------------------------------------------------------

DATES: Registered bulk manufacturers of the affected basic classes, and 
applicants therefore, may file written comments on or objections to the 
issuance of the proposed registration on or before December 23, 2019.

ADDRESSES: Written comments should be sent to: Drug Enforcement 
Administration, Attention: DEA Federal Register Representative/DPW, 
8701 Morrissette Drive, Springfield, Virginia 22152.

SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.33(a), this 
is notice that on September 10, 2019, Johnson Matthey, Inc., 2003 Nolte 
Drive, West Deptford, New Jersey 08066-1743 applied to be registered as 
a bulk manufacturer of the following basic classes of controlled 
substances:

------------------------------------------------------------------------
      Controlled substance           Drug code           Schedule
------------------------------------------------------------------------
Gamma Hydroxybutyric Acid.......            2010  I
Marihuana.......................            7360  I
Tetrahydrocannabinols...........            7370  I
Dihydromorphine.................            9145  I
Difenoxin.......................            9168  I
Amphetamine.....................            1100  II
Methamphetamine.................            1105  II
Lisdexamfetamine................            1205  II
Methylphenidate.................            1724  II
Nabilone........................            7379  II
Cocaine.........................            9041  II
Codeine.........................            9050  II
Dihydrocodeine..................            9120  II
Oxycodone.......................            9143  II
Hydromorphone...................            9150  II
Diphenoxylate...................            9170  II
Ecgonine........................            9180  II
Hydrocodone.....................            9193  II
Levorphanol.....................            9220  II
Meperidine......................            9230  II
Methadone.......................            9250  II
Methadone intermediate..........            9254  II
Morphine........................            9300  II
Thebaine........................            9333  II
Opium tincture..................            9630  II
Oxymorphone.....................            9652  II
Noroxymorphone..................            9668  II
Alfentanil......................            9737  II
Remifentanil....................            9739  II
Sufentanil......................            9740  II
Tapentadol......................            9780  II
Fentanyl........................            9801  II
------------------------------------------------------------------------

    The company plans to bulk manufacture the listed controlled 
substances for internal use as intermediates or for sale to its 
customers. In reference to drug codes 7360 (marihuana), and 7370 
(tetrahydrocannabinols), the company plans to bulk manufacture these 
drugs as synthetic. No other activities for these drug codes are 
authorized for this registration.

    Dated: October 9, 2019.
William T. McDermott,
Acting Assistant Administrator.
[FR Doc. 2019-23012 Filed 10-21-19; 8:45 am]
 BILLING CODE 4410-09-P